Adiponectin treatment causes suppression of tumor angiogenesis in liver cancer cells since it downregulates ROCK/IP10/angiopoietin 1/MMP-9/VEGF cell signaling in tumor tissue, which contributes to inhibition of tube formation of tumor endothelial cells, their damage, and decreased microvessel density. The gene discussed is MMP9; the disease is liver cancer.